Regular coffee consumption (2-3 cups/day) protects against liver cirrhosis, reduces fibrosis, prevents liver cancer, and ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according to a study ...

The following is a summary of “Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With ...

Patients with metabolic dysfunction–associated steatotic liver disease experience poor sleep due to sleep fragmentation and ...

This study evaluated the impact of obesity and diabetes mellitus on HCC recurrence and survival after hepatic resection, ...

Galectin’s shares tanked in premarket trading Friday after the biotech revealed its lead asset missed the primary endpoint ...

Hepatic encephalopathy – cognitive impairment caused by liver failure – impacts more than 40 percent of patients with ...

WHAT YOU CAN DO: Current Akero shareholders who have held Akero shares since on or before September 13, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...